J Mark Pohl

Title: The Innovations of J Mark Pohl: Enhancing Prasterone Bioavailability

Introduction

J Mark Pohl is an innovative inventor based in Morristown, NJ, specializing in advancements within the pharmaceutical sector. With a total of two patents to his name, Pohl is committed to improving drug formulations, particularly focusing on the oral bioavailability of prasterone.

Latest Patents

Pohl's latest patents center around "Dosage form to increase prasterone bioavailability." This groundbreaking formulation increases the oral bioavailability of prasterone while reducing variability in its absorption. In contrast to previous methods, Pohl’s approach is scalable for commercial production and adheres to regulatory standards. Additionally, the product can be analyzed using established quantitative analytical techniques, ensuring conformity with industry regulations.

Career Highlights

J Mark Pohl currently works with Health Science Funding, LLC, where he leverages his expertise to further research and development in health sciences. His focus on enhancing drug formulations has made significant contributions to the field, ensuring that medications are more effective and reliable for patients.

Collaborations

Throughout his career, Pohl has engaged with various stakeholders in the healthcare and pharmaceutical industries, enhancing the impact of his inventions and fostering partnerships that aim to push the boundaries of current medical technologies. His collaborations have been instrumental in developing new methodologies for drug formulation and delivery.

Conclusion

J Mark Pohl is a notable figure in the realm of pharmaceutical innovation, particularly recognized for his work on prasterone formulations. His contributions reflect a profound commitment to improving drug bioavailability, which is crucial for enhancing patient outcomes. As he continues his work with Health Science Funding, LLC, Pohl is poised to deliver more transformative innovations in the future.